An ionic control of metabolic-epigenetic reprogramming links inflammation to membrane potential-mediated nutrient acquisition
Di Wang,Weiwei Yu,Zhen Wang,Xiafei Yu,Zhexu Chi,Kailian Zhang,Sheng Chen,Ting Xu,Danlu Jiang,Xingchen Guo,Mobai Li,Jian Zhang,Hui Fang,Qizhen Ye,Xuyan Yang,Xue Zhang,Yingliang Wu,Wei Yang
DOI: https://doi.org/10.21203/rs.3.rs-85111/v1
2020-01-01
Abstract:Abstract Metabolic and epigenetic reprogramming play pivotal roles in driving inflammation, but the precise regulatory mechanisms remain minimally understood. Here we show an ionic control mediated by macrophage Kir2.1, an inwardly-rectifying K+ channel, promting lipopolysaccharide (LPS)-induced inflammation. Kir2.1 blockade by the selective inhibitor ML133 or its specific deletion in macrophages suppressed the production of LPS-induced inflammatory factors, such as interleukin-1β, and protected mice from LPS-induced sepsis in vivo. Kir2.1 loss-of-function led to a nutrient starvation phenotype, with impaired glucose and serine-glycine-one-carbon metabolism, whose synergy promotes the generation of S-adenosylmethionine (SAM). Accordingly, reduced SAM availability by Kir2.1 blockade decreased histone methylation at key inflammatory effector loci, such as Il1b. Although the immunomodulatory effect of Kir2.1 was independent of modulation by Ca2+ flux and general signaling pathways, its loss-of-function led to a depolarized membrane potential (Vm) which decreased the surface expression of nutrient transporters, including GLUT1 and CD98. We thus identify an ionic control of metabolic- epigenetic reprogramming that links inflammation to Vm-mediated nutrient acquisition and identifies potential new strategies for anti-inflammatory therapy.